Published in Transplant Proc on February 01, 1991
The use of the Papworth cocktail is detrimental to steatotic livers after ischemia-reperfusion injury. Transplantation (2008) 1.41
Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol (2002) 1.32
One thousand liver transplants. The lessons learned. Ann Surg (1994) 1.12
Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg (2005) 1.03
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg (2004) 0.91
Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation. Transpl Immunol (2012) 0.88
The association between preoperative chemotherapy and the prevalence of hepatic steatosis in hepatectomy for metastatic colorectal cancer. Arq Bras Cir Dig (2014) 0.84
Donor liver histology--a valuable tool in graft selection. Langenbecks Arch Surg (2015) 0.79
Metabolic syndrome and hepatic resection: improving outcome. HPB (Oxford) (2011) 0.78
Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease. World J Transplant (2014) 0.78
Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation. Dig Dis Sci (1998) 0.77
Hyaluronate levels in donor organ washout effluents: a simple and predictive parameter of graft viability. Liver (1996) 0.75
Right hepatectomy in patients over 70 years of age: an analysis of liver function and outcome. World J Surg (2012) 0.75
BCG in the treatment of acute lymphocytic leukemia. Blood (1975) 9.88
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
24-hour and 72-hour preservation of canine kidneys. Lancet (1967) 3.81
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med (1999) 3.41
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A (1997) 3.25
Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93
Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89
The assessment of insight in psychosis. Br J Psychiatry (1992) 2.73
Recognizing emotion in faces: developmental effects of child abuse and neglect. Dev Psychol (2000) 2.55
A method of assessment during vocational training: report of a pilot study. J R Coll Gen Pract (1985) 2.32
Cause of renal injury in kidneys obtained from cadaver donors. Surg Gynecol Obstet (1970) 2.20
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
Experience with reduced-size liver transplantation. Surg Gynecol Obstet (1990) 1.87
Preservation and transplantation of human cadaver kidneys: a two-year experience. Ann Surg (1970) 1.83
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst (1998) 1.78
Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg (1968) 1.76
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol (1995) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Intestinal necrosis and perforation after renal transplantation. Arch Surg (1975) 1.59
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology (1997) 1.55
72-hour preservation of the canine pancreas. Transplantation (1987) 1.55
CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant (2008) 1.55
Treatment of symptomatic gastroesophageal reflux using the Angelchik prosthesis. Ann Surg (1982) 1.53
Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53
Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med (1968) 1.52
Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens (2004) 1.50
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Contemporary referral of patients from community care to cardiology lack diagnostic and clinical detail. Int J Clin Pract (2006) 1.49
The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation (1991) 1.45
The correlation of MLC with graft survival. Transplant Proc (1973) 1.44
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
Primary orbital Ewing sarcoma in a middle-aged woman. Arch Ophthalmol (1999) 1.43
Organ preservation. Annu Rev Med (1995) 1.43
Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am (1971) 1.40
A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant (2006) 1.40
Is there any role for antithymocyte induction in renal transplantation? Transplant Proc (2010) 1.39
Unaltered graft survival and intragraft lymphocytes infiltration in the cardiac allograft of Cxcr3-/- mouse recipients. Am J Transplant (2008) 1.36
Pyramidal appearance and resistive index: insensitive and nonspecific sonographic indicators of renal transplant rejection. AJR Am J Roentgenol (1990) 1.36
Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg (1974) 1.36
Short term preservation of porcine livers. J Surg Res (1970) 1.34
Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation (1988) 1.33
Liver transplantation from controlled non-heart-beating donors. Surgery (2000) 1.32
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation (1995) 1.32
Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am J Neuroradiol (1999) 1.32
Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. Transplantation (1987) 1.31
Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg (1993) 1.31
Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Features, natural history, and management. Am J Obstet Gynecol (1986) 1.29
Improved patient survival in renal transplantation. Surgery (1976) 1.25
Alpha 1-adrenergic effects and liver regeneration. Hepatology (1988) 1.25
Important components of the UW solution. Transplantation (1990) 1.24
Comparison between duodenal button and duodenal segment in pancreas transplantation. Transplantation (1989) 1.21
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. Am J Transplant (2014) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med (1986) 1.18